BioCentury | Jul 27, 2015
Company News
Memcine, Spotlight Innovation deal
...Spotlight acquired an 82% stake in Memcine, which is developing its Immunoplex vaccine platform technology to...
...Spotlight is an incubator focused on the medical sector. Memcine did not respond to inquiries. Memcine Pharmaceuticals Inc....
...Spotlight is an incubator focused on the medical sector. Memcine did not respond to inquiries. Memcine Pharmaceuticals Inc....